Article Text
PDF
Other content recommended for you
- Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Exploring the ethics of tuberculosis human challenge models
- Better recognition for research participants: what society should learn from covid-19
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Ethics of research at the intersection of COVID-19 and black lives matter: a call to action
- Uncertainty associated with parents of preterm infants hospitalised in neonatal intensive care unit among selected governmental hospitals in Addis Ababa, Ethiopia, 2022: an institution-based cross-sectional study
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment